Friday, June 11, 2021 5:30:00 PM
Time will show that to be true.
To your magnet comments... enjoy that CROW, like a little salt with that?
Now this from another company I'm invested in. "Check out #3" I knew it, I knew it.
William A. Hartman, Halberd's Chairman, President & CEO, commented, "Halberd now has four antibodies specifically targeting the SARS-CoV-2 Spike Protein antigen.
JACKSON CENTER, PA / ACCESSWIRE / June 7, 2021
Hartman continued, "Together with our patented extracorporeal treatment process, we believe we have an effective method of treating viruses and bacterial infections which are resistant to conventional therapies. Halberd's strategy continues to follow our process road map consisting of:
1. Identifying a target antigen;
2. Creating patentable antibodies with high binding affinity against the target antigen;
3. Conjugating these antibodies with metallic nanoparticles (moieties) through a patent-pending process;
4. Applying Halberd's patented extracorporeal process of eradicating the moiety-antigen complex in bodily fluids through the patent-pending process of exposing it to radiofrequency waves or laser emissive energy;
5. Conducting animal testing to establish the safety and efficacy of our revolutionary process for the eradication of diseases."
"We have successfully completed steps 1, 2, & 3. We are in the process of executing Step 4 for effectiveness against the SARS-Cov-2 spike protein and E. coli bacteria. This will be followed by executing animal testing, for which the groundwork is already being laid."
Recent TPTW News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 02:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:18:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 02:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/10/2024 09:24:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 07:44:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 05:49:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 07:18:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/05/2023 09:02:48 PM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM